CA2078667A1 - Vecteur d'expression de la proteine c humaine - Google Patents

Vecteur d'expression de la proteine c humaine

Info

Publication number
CA2078667A1
CA2078667A1 CA 2078667 CA2078667A CA2078667A1 CA 2078667 A1 CA2078667 A1 CA 2078667A1 CA 2078667 CA2078667 CA 2078667 CA 2078667 A CA2078667 A CA 2078667A CA 2078667 A1 CA2078667 A1 CA 2078667A1
Authority
CA
Canada
Prior art keywords
human protein
fragment
dna
gene
introns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2078667
Other languages
English (en)
Inventor
Masahiko Suzuki
Kenji Wakabayashi
Yoshiharu Takazawa
Yoshihiko Sumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2078667A1 publication Critical patent/CA2078667A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6464Protein C (3.4.21.69)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA 2078667 1991-01-29 1992-01-28 Vecteur d'expression de la proteine c humaine Abandoned CA2078667A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2673991 1991-01-29
JP3/26739 1991-01-29

Publications (1)

Publication Number Publication Date
CA2078667A1 true CA2078667A1 (fr) 1992-07-30

Family

ID=12201672

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2078667 Abandoned CA2078667A1 (fr) 1991-01-29 1992-01-28 Vecteur d'expression de la proteine c humaine

Country Status (5)

Country Link
EP (1) EP0530365A1 (fr)
JP (1) JPH05276952A (fr)
AU (1) AU1180692A (fr)
CA (1) CA2078667A1 (fr)
WO (1) WO1992013079A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08511423A (ja) * 1993-06-10 1996-12-03 ジェネティック セラピー,インコーポレイテッド 血友病治療のためのアデノウイルスベクター
US5618714A (en) * 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
JP2009198506A (ja) * 2009-04-10 2009-09-03 Shino Test Corp 血液凝固反応抑制血漿タンパク質の活性測定方法及び活性測定試薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
DE3545126A1 (de) * 1985-12-19 1987-06-25 Boehringer Mannheim Gmbh Verfahren zur verbesserung der expression von eukaryontenprotein
EP0255320A3 (fr) * 1986-07-28 1989-09-06 Genzyme Corporation Production de protéines dans des cellules de myélomes

Also Published As

Publication number Publication date
AU1180692A (en) 1992-08-27
EP0530365A1 (fr) 1993-03-10
JPH05276952A (ja) 1993-10-26
WO1992013079A1 (fr) 1992-08-06

Similar Documents

Publication Publication Date Title
JP2749083B2 (ja) 活性化されたヒトプロテインcの直接発現のためのベクターおよび化合物
KR970002166B1 (ko) 단백질 c를 암호화하는 dna 서열, 이를 함유하는 재조합 벡터, 재조합 벡터를 함유하는 포유동물 세포 및 단백질 c를 제조하는 방법
US5225537A (en) Methods for producing hybrid phospholipid-binding proteins
US4740461A (en) Vectors and methods for transformation of eucaryotic cells
US6114146A (en) Expression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical composition
JP2688407B2 (ja) ヒトプロテインcの製造方法
EP0296413A2 (fr) Protéine C hybride et sa méthode de préparation
EP0354504A2 (fr) Constructions des hybrides de la protéine C et procédé pour leur préparation
JP2003504082A (ja) エカリンポリペプチド、エカリンをコードするポリヌクレオチド、及びその利用のための方法
JPH05103678A (ja) チモーゲン型ヒトプロテインcの発現のためのベクターおよび化合物
JP3004375B2 (ja) ヒトプロテインcのグリコシル化突然変異体の発現のためのベクターおよび化合物
US5196322A (en) Vectors and compounds for expression of zymogen forms of human protein C
JPH0576374A (ja) 組織プラスミノーゲンアクチベーターの翻訳後プロセツシングを改変するための方法
JP2851287B2 (ja) 酵素前駆体型ヒトプロテインcの発現のためのベクターおよび化合物
CA2078667A1 (fr) Vecteur d'expression de la proteine c humaine
EP0485504B1 (fr) Procedes de culture de cellules pour la production de proteine c activee
WO1991012320A1 (fr) Proteine c activee a chaine legere tronquee
CA1338260C (fr) Proteine-s humaine, regulatrice de la proteine plasmatique de l'hemostase

Legal Events

Date Code Title Description
FZDE Dead